Zoltán
Zoltán Bakos, Szada HU
Zoltán Bordacs, Veszprem HU
Patent application number | Description | Published |
---|---|---|
20110052419 | Method for Regenerating a Compressed Air Supply Device, Control Unit and Compressed Air Supply Device - To regenerate a compressed air supply device of a commercial vehicle, a first compressed air circuit is supplied with compressed air until reaches a predetermined target pressure value; then a second compressed air circuit is supplied. Between these steps, the method: (1) regenerates an air dryer when the pressure in the first compressed air circuit has reached the target pressure value, and when a moisture value of the air dryer exceeds a predetermined target moisture value; (2) terminates the regeneration when the pressure has dropped to a predetermined limit pressure value or the moisture value of the air dryer has reached or dropped below the target moisture value; (3) supplies the first compressed air circuit until it has reached the predetermined target pressure value; and (4) repeats the preceding intermediate steps when the moisture value is greater than the target moisture value. | 03-03-2011 |
Zoltán Bordacs, Veszprem HU
Patent application number | Description | Published |
---|---|---|
20100071779 | Compressed Air Supply System for a Commercial Vehicle, and Method for Operating a Compressed Air Supply System - A compressed air supply system for a commercial vehicle includes a compressed air inlet that can be coupled to a compressor, a filter unit that is coupled to the compressed air inlet via a delivery line, a discharge valve unit that is coupled to a discharge outlet and the delivery line, an energy saving control output that can be coupled to a control input of the compressor, a first valve unit and a second valve unit, wherein the discharge value unit, the energy saving control output, and the regeneration of the filter unit can be controlled via the value units. A first control input of the discharge value unit, the energy saving control output and the regeneration of the filter unit can be controlled via the first value unit. A second control input of the discharge value unit can be controlled via the second value unit. A method is provided for operating the compressed air supply system. | 03-25-2010 |
20110052419 | Method for Regenerating a Compressed Air Supply Device, Control Unit and Compressed Air Supply Device - To regenerate a compressed air supply device of a commercial vehicle, a first compressed air circuit is supplied with compressed air until reaches a predetermined target pressure value; then a second compressed air circuit is supplied. Between these steps, the method: (1) regenerates an air dryer when the pressure in the first compressed air circuit has reached the target pressure value, and when a moisture value of the air dryer exceeds a predetermined target moisture value; (2) terminates the regeneration when the pressure has dropped to a predetermined limit pressure value or the moisture value of the air dryer has reached or dropped below the target moisture value; (3) supplies the first compressed air circuit until it has reached the predetermined target pressure value; and (4) repeats the preceding intermediate steps when the moisture value is greater than the target moisture value. | 03-03-2011 |
Zoltán BordÁcs, Veszprem HU
Patent application number | Description | Published |
---|---|---|
20100071779 | Compressed Air Supply System for a Commercial Vehicle, and Method for Operating a Compressed Air Supply System - A compressed air supply system for a commercial vehicle includes a compressed air inlet that can be coupled to a compressor, a filter unit that is coupled to the compressed air inlet via a delivery line, a discharge valve unit that is coupled to a discharge outlet and the delivery line, an energy saving control output that can be coupled to a control input of the compressor, a first valve unit and a second valve unit, wherein the discharge value unit, the energy saving control output, and the regeneration of the filter unit can be controlled via the value units. A first control input of the discharge value unit, the energy saving control output and the regeneration of the filter unit can be controlled via the first value unit. A second control input of the discharge value unit can be controlled via the second value unit. A method is provided for operating the compressed air supply system. | 03-25-2010 |
Zoltán Daliczek, Meziikovacshaza HU
Patent application number | Description | Published |
---|---|---|
20130281700 | PALLADIUM CATALYST, METHOD FOR ITS PREPARATION AND ITS USE - The invention relates to palladium(0)-tris{tri-[3,5-bis(trifluoromethyl)-phenyl]-phosphine} complex of formula (I), as well as to its preparation and use. | 10-24-2013 |
Zoltán Fehér, Budakeszi HU
Patent application number | Description | Published |
---|---|---|
20120307791 | Methods and Devices for Controlling Handover - Methods and devices in a cellular radio system for handling repeated handovers of a user equipment between a pair of cells is provided. It is determined if the user equipment is in one of two states, moving state or stationary state. Based on the determination different actions can be taken. For example threshold optimizations for reducing repeated handover may only be applied to a user equipment determined to be in a stationary state or a user equipment determined to be in a stationary state to can be nailed to the best cell of said pair of cells by not allowing the user equipment to handover to the other cell of said pair of cells. | 12-06-2012 |
Zoltán Finta, Budapest HU
Patent application number | Description | Published |
---|---|---|
20130281700 | PALLADIUM CATALYST, METHOD FOR ITS PREPARATION AND ITS USE - The invention relates to palladium(0)-tris{tri-[3,5-bis(trifluoromethyl)-phenyl]-phosphine} complex of formula (I), as well as to its preparation and use. | 10-24-2013 |
Zoltán Greff, Budapest HU
Patent application number | Description | Published |
---|---|---|
20090298842 | Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor - Described herein is the discovery that certain mycobacterial serine/threonine protein kinases, particularly protein kinase G (PknG), are effective therapeutic targets for the treatment of mycobacterial infections. Furthermore, the present application refers to the use of mycobacterial serine/threonine protein kinases for developing methods for detection and determination of these kinases for recognizing and monitoring diseases and for controlling therapy of diseases. Additionally disclosed are novel 4,5,6,7-tetrahydrobenzo[b]thiophene compounds, benzo(g)quinoxaline compounds, and pharmaceutically acceptable salts thereof, and methods of using such compounds and salts thereof for the prophylaxis and/or treatment of virally and/or bacterially induced infections, particularly mycobacteria-induced infections, including opportunistic infections, as well as pharmaceutical compositions containing at least one 4,5,6,7-tetrahydrobenzo[b]thiophene compound and/or benzo(g)quinoxaline compound and/or pharmaceutically acceptable salts thereof in a pharmaceutically acceptable carrier. | 12-03-2009 |
20120258968 | 4-PHENYLAMINO-PYRIMIDINE DERIVATIVES HAVING PROTEIN KINASE INHIBITOR ACTIVITY - The invention relates compounds of general formula (I) and pharmaceutically acceptable salts and solvates thereof wherein | 10-11-2012 |
Zoltán Györy, Debrecen HU
Patent application number | Description | Published |
---|---|---|
20130195830 | PERORALLY APPLICABLE PREPARATION CONTAINING HISTAMINASE OF VEGETABLE ORIGIN, RESISTANT TO PEPSIN AND TRYPSIN AND A PROCESS FOR PRODUCING IT - The subject of the invention is a perorally applicable preparation of vegetable origin, resistant to pepsin and trypsin, based on histaminase, optionally for the use as an agent for improving digestion, reducing appetite or reducing body weight. The preparation of the invention is a pressed juice—which is optionally in lyophilized form—obtained from seedlings of pea ( | 08-01-2013 |
Zoltán Horváth, Budapest HU
Patent application number | Description | Published |
---|---|---|
20090298842 | Novel therapeutic targets for the treatment of mycobacterial infections and compounds useful therefor - Described herein is the discovery that certain mycobacterial serine/threonine protein kinases, particularly protein kinase G (PknG), are effective therapeutic targets for the treatment of mycobacterial infections. Furthermore, the present application refers to the use of mycobacterial serine/threonine protein kinases for developing methods for detection and determination of these kinases for recognizing and monitoring diseases and for controlling therapy of diseases. Additionally disclosed are novel 4,5,6,7-tetrahydrobenzo[b]thiophene compounds, benzo(g)quinoxaline compounds, and pharmaceutically acceptable salts thereof, and methods of using such compounds and salts thereof for the prophylaxis and/or treatment of virally and/or bacterially induced infections, particularly mycobacteria-induced infections, including opportunistic infections, as well as pharmaceutical compositions containing at least one 4,5,6,7-tetrahydrobenzo[b]thiophene compound and/or benzo(g)quinoxaline compound and/or pharmaceutically acceptable salts thereof in a pharmaceutically acceptable carrier. | 12-03-2009 |
Zoltán Hórvögyi, Budapest HU
Patent application number | Description | Published |
---|---|---|
20130140980 | FLUORESCENT LAMP OF IMPROVED LUMEN MAINTENANCE AND MERCURY CONSUMPTION - The inner surfaces of fluorescent lamp tubing are provided with a phosphor coating. The phosphor coating defines an inward-facing surface. A protective coating is deposited on the inward-facing surface of the phosphor coating. The protective coating defines an innermost surface and makes effective recombination of Hg ions possible on the innermost surface of the second coating before the Hg ions collide with the phosphor particles in the phosphor coating. | 06-06-2013 |
Zoltán Kapui, Budapest HU
Patent application number | Description | Published |
---|---|---|
20100210838 | FLUOROPYRROLIDINES HAVING DIPEPTIDYL PEPTIDASE ENZYME INHIBITORY ACTIVITY - The present invention relates to new, potent DPP-IV enzyme inhibitors of the general formula (I), which contain fluorine atoms. | 08-19-2010 |
20110118305 | COMPOUNDS - Heterocyclic amides useful as inhibitors of dipeptylpeptidase-IV (DPP-IV) enzyme, process for the preparation thereof and intermediates therefore. | 05-19-2011 |
Zoltán Konthur, Berlin DE
Patent application number | Description | Published |
---|---|---|
20110045490 | BIOMARKER FOR THE PREDICTION OF RESPONSIVENESS TO AN ANTI-TUMOUR NECROSIS FACTOR ALPHA (TNF) TREATMENT - The invention refers to a method for diagnosing an individual who is to be subjected to or is being subjected to an anti-tumour necrosis factor alpha (TNFα or TNF) treatment to assess the responsiveness to an anti-TNF treatment which comprises the detection of immunoglobulin(s) against one or more biomarker proteins in a bodily fluid or an excrement of said patient, and sorting the individual into one of two categories based on detection of said immunoglobulin(s), wherein individuals are classified as NON-responder or responder. The invention refers to diagnostic kits comprising said one or more biomarker proteins and the use of these kits for assessing the responsiveness to an anti-TNF treatment of an individual who is to be subjected to or is being subjected to an anti-TNFα treatment. | 02-24-2011 |
20150024973 | BIOMARKER FOR THE PREDICTION OF RESPONSIVENESS TO AN ANTI-TUMOUR NECROSIS FACTOR ALPHA (TNF) TREATMENT - The invention refers to a method for diagnosing an individual who is to be subjected to or is being subjected to an anti-tumour necrosis factor alpha (TNFα or TNF) treatment to asses the responsiveness to an anti-TNF treatment which comprises the detection of immunoglobulin(s) against one or more biomarker proteins in a bodily fluid or an excrement of said patient, and sorting the individual into one of two categories based on detection of said immunoglobulin(s), wherein individuals are classified as NON-responder or responder. The invention refers to diagnostic kits comprising said one or more biomarker proteins and the use of these kits for assessing the responsiveness to an anti-TNF treatment of an individual who is to be subjected to or is being subjected to an anti-TNFα treatment. | 01-22-2015 |
Zoltán Konthur, Berlin DE
Patent application number | Description | Published |
---|---|---|
20110045490 | BIOMARKER FOR THE PREDICTION OF RESPONSIVENESS TO AN ANTI-TUMOUR NECROSIS FACTOR ALPHA (TNF) TREATMENT - The invention refers to a method for diagnosing an individual who is to be subjected to or is being subjected to an anti-tumour necrosis factor alpha (TNFα or TNF) treatment to assess the responsiveness to an anti-TNF treatment which comprises the detection of immunoglobulin(s) against one or more biomarker proteins in a bodily fluid or an excrement of said patient, and sorting the individual into one of two categories based on detection of said immunoglobulin(s), wherein individuals are classified as NON-responder or responder. The invention refers to diagnostic kits comprising said one or more biomarker proteins and the use of these kits for assessing the responsiveness to an anti-TNF treatment of an individual who is to be subjected to or is being subjected to an anti-TNFα treatment. | 02-24-2011 |
20110311999 | DIAGNOSTIC PREDICTION OF RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS - The present invention pertains to a diagnostic assay for the diagnosis of an autoimmune disease. The present invention provides an improved diagnostic assay for the diagnosis of an autoimmune disease, particularly rheumatoid arthritis (RA) and Systemic Lupus Erythematosus (SLE). In particular the invention pertains to a method of determining in a sample of a subject the presence of two or more antibodies comprising the step of determining whether an antibody is present in a sample that specifically recognizes a hnRNP-DL polypeptide or a fragment thereof or a splice variant thereof and the further step of determining whether at least one further antibody is present in the sample that specifically recognizes a at least one other hnRNP polypeptide which is not sequence homologue to said hnRNP-DL polypeptide or fragments thereof or splice variants thereof, and/or said CCP peptide and/or a polypeptide comprising at least the Fc-part of IgG, respectively. The invention also relates to polypeptides, protein sets and antibodies that may be used in such methods and assays and for therapeutic use in RA and SLE patients. | 12-22-2011 |
Zoltán Mandzsu, Budapest HU
Patent application number | Description | Published |
---|---|---|
20120261278 | PACKAGING CONTAINER WITH OVERPRESSURE RELIEF, PACKING METHOD AND SYSTEM - The invention relates to packaging container, packaging method and system. | 10-18-2012 |
Zoltán Nagy C, Szeged HU
Patent application number | Description | Published |
---|---|---|
20130148499 | Efficient Flow Control in a Radio Network Controller (RNC) - A mechanism is provided to resolve the Iub transport network congestion efficiently for HSDPA by dynamic adjustment of the transmit window of the RLC. The RLC protocol is extended with congestion control functionality. The Iub TN and Uu congestion detection method in the Node-B signals the congestion to the RNC, and this congestion indication is used by RLC to react on the congestion situation. In the RNC, the transmission window of the RLC is adjusted to control the flow rate. When congestion is detected, the RLC transmission window size is decreased. When there is no congestion, then the RLC transmission window size is increased automatically. Different types of congestion are distinguished and are handled in different ways. Alternatively, congestion control is achieved without any modification in the RLC layer from the existing standard. Here, RLC STATUS PDUs are used to change the RLC transmission window size. | 06-13-2013 |
Zoltán Német, Budapest HU
Patent application number | Description | Published |
---|---|---|
20120059034 | NOVEL CRYSTALLINE HYDRATE, AMORPHOUS AND POLYMORPHIC FORMS OF DIHYDRO-BENZOXAZOLE-6-YL-ACETAMIDE DERIVATIVE AND PROCESSES FOR THEIR PREPARATION - The invention relates to novel crystalline hydrate, amorphous and crystalline polymorphic forms of 2-[4-(4-Fluoro-benzyl)-piperidine-1-yl]-2-oxo-N-(2-oxo-2,3-dihydro-benzoxazole-6-yl)-acetamide (I) (radiprodil). Processes for the preparation of these forms, compositions containing these forms, and methods of use thereof are also described. | 03-08-2012 |
Zoltán Noszticzius, Budapest HU
Patent application number | Description | Published |
---|---|---|
20100189631 | PERMEATION METHOD AND APPARATUS FOR PREPARING FLUIDS CONTAINING HIGH PURITY CHLORINE DIOXIDE - Method to prepare fluids (liquids and gases) containing pure chlorine dioxide which is not contaminated by the starting materials or the byproducts of the chlorine dioxide synthesis or to deliver pure chlorine dioxide into any medium capable of dissolving chlorine dioxide, wherein the chlorine dioxide generated in the process is transported across a pore free polymeric membrane via selective permeation into the target medium. Apparatus to realize the said method, wherein the generation of chlorine dioxide is carried out in such a reactor where some or all walls comprising the reactor, or the walls of a permeator unit attached to the reactor, are made of the said pore free polymer, characteristically some kind of silicone rubber, which is highly permeable to chlorine dioxide, but which is practically impermeable for the acidic and corrosive reagents used for the chlorine dioxide synthesis, its permeability being at least 3 orders of magnitude lower for these contaminating components compared to that of chlorine dioxide. The invention can be realized both by batch and by continuous reactors. | 07-29-2010 |
Zoltán Noszticzius, Budapest HU
Patent application number | Description | Published |
---|---|---|
20100189631 | PERMEATION METHOD AND APPARATUS FOR PREPARING FLUIDS CONTAINING HIGH PURITY CHLORINE DIOXIDE - Method to prepare fluids (liquids and gases) containing pure chlorine dioxide which is not contaminated by the starting materials or the byproducts of the chlorine dioxide synthesis or to deliver pure chlorine dioxide into any medium capable of dissolving chlorine dioxide, wherein the chlorine dioxide generated in the process is transported across a pore free polymeric membrane via selective permeation into the target medium. Apparatus to realize the said method, wherein the generation of chlorine dioxide is carried out in such a reactor where some or all walls comprising the reactor, or the walls of a permeator unit attached to the reactor, are made of the said pore free polymer, characteristically some kind of silicone rubber, which is highly permeable to chlorine dioxide, but which is practically impermeable for the acidic and corrosive reagents used for the chlorine dioxide synthesis, its permeability being at least 3 orders of magnitude lower for these contaminating components compared to that of chlorine dioxide. The invention can be realized both by batch and by continuous reactors. | 07-29-2010 |
Zoltán Ördögh, Tampere FI
Patent application number | Description | Published |
---|---|---|
20080294729 | EMAIL OBJECT FOR OPEN MOBILE ALLIANCE DATA SYNCHRONIZATION USAGE - An email object is provided that fulfills requirements defined in the OMA MEM Enabler, where email messages are represented as extensible markup language documents. Filters created using XPath allow an email client to indicate what email messages are to be advertised as new and later downloaded. Table of content information can also be provided without the need for downloading an entire email object first, as well as additional information about each body part. Therefore, referencing body parts for downloading email body parts step-by-step or for use in a reply/forward without download use case, as well as allowing for the downloading of alternative content (e.g., content-adaptation) is provided. Data synchronization protocols are used to allow the email client to keep an equivalence relationship between main email storage on the email server and local mail storage on the email client side when transferring email messages between the email client and email server. | 11-27-2008 |
20100121709 | INVITATION-BASED VIRAL ADVERTISING - Direct and indirect invitation-based viral advertising is provided, where an advertisement is delivered to a first user. The first user may send an invitation message to a second user inviting him/her to view/interact with the advertisement. The invitation message can be sent directly from the first user's device or indirectly sent from an advertising server. Upon acceptance by the second user of the invitation message regarding the advertisement, an opt-in form an optional opt-in form, or no opt-in form is presented to the second user. The opt-in form can be used by the second user to register with an advertising network that created, is associated with, and/or originally delivered the advertisement to the first user. Upon receipt of opt-in information associated with the second user for populating/answering the opt-in form, the opt-in form is processed for the second user. Then, the advertisement is delivered to the second user. | 05-13-2010 |
20100122110 | METHOD AND APPARATUS FOR MANAGING ADVERTISING-ENABLED APPLICATIONS - A method comprises determining a condition of a resource for a user device, the device having an advertisement application thereon; and sending a notification indicative of the condition of the resource to the advertisement application. | 05-13-2010 |
20100219979 | METHOD AND APPARATUS FOR PROVIDING DEVICE RECOVERY ASSISTANCE - An apparatus for providing device recovery assistance may include at least one processor and at least one memory including computer program code. The at least one memory and the computer program code may be configured, with the processor, to cause the apparatus to perform at least causing a device to be registered with a service, receiving a verification procedure from a platform associated with the service, the verification procedure defining device recovery parameters associated with maintenance of a loss status indicator indicating a loss status of the device, causing a device identifier associated with the device to be stored in a permanent storage medium of the device, and enabling device location reporting based on the received verification procedure in response to a determination that the device is classified as lost or stolen. A corresponding method and computer program product are also provided. | 09-02-2010 |
Zoltán Ördögh, Tampere FI
Patent application number | Description | Published |
---|---|---|
20100122110 | METHOD AND APPARATUS FOR MANAGING ADVERTISING-ENABLED APPLICATIONS - A method comprises determining a condition of a resource for a user device, the device having an advertisement application thereon; and sending a notification indicative of the condition of the resource to the advertisement application. | 05-13-2010 |
20100219979 | METHOD AND APPARATUS FOR PROVIDING DEVICE RECOVERY ASSISTANCE - An apparatus for providing device recovery assistance may include at least one processor and at least one memory including computer program code. The at least one memory and the computer program code may be configured, with the processor, to cause the apparatus to perform at least causing a device to be registered with a service, receiving a verification procedure from a platform associated with the service, the verification procedure defining device recovery parameters associated with maintenance of a loss status indicator indicating a loss status of the device, causing a device identifier associated with the device to be stored in a permanent storage medium of the device, and enabling device location reporting based on the received verification procedure in response to a determination that the device is classified as lost or stolen. A corresponding method and computer program product are also provided. | 09-02-2010 |
Zoltán Ördögh, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20120324019 | SPAM MANAGEMENT AND REPORTING IN A MOBILE DEVICE - Spam management by a mobile device includes transmitting an IMAP command to a voicemail server, the IMAP command identifying a voicemail associated with the mobile communication device as being a spam message; and receiving, relative to the IMAP command, a response regarding the spam message from the voicemail server. | 12-20-2012 |
Zoltán Szilágyi, Karben DE
Patent application number | Description | Published |
---|---|---|
20120004147 | COATED PARTICLES OF A CHELATING AGENT - The present invention relates to a coated particle including a particle including at least one chelating agent of the formula COOH—CHX—N—(CH | 01-05-2012 |
Zoltán Szilágyi, Karben DE
Patent application number | Description | Published |
---|---|---|
20120004147 | COATED PARTICLES OF A CHELATING AGENT - The present invention relates to a coated particle including a particle including at least one chelating agent of the formula COOH—CHX—N—(CH | 01-05-2012 |
Zoltán Szilvássy, Debrecen-Jozsa HU
Patent application number | Description | Published |
---|---|---|
20090054487 | Pharmaceutical composition for increasing the mitochondrial genesis - The invention refers to the use of O-(3-piperidino-2-hydroxypropyl)nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof for the preparation of a pharmaceutical composition increasing the mitochondrial genesis. | 02-26-2009 |
20090149498 | Pharmaceutical composition having prokinetic effect - The invention refers to the use of O-(3-piperidino-2-hydroxypropyl)nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof for the preparation of a pharmaceutical composition that restores and/or enhances the activity of the neuronal nitric oxide synthase enzyme. | 06-11-2009 |
20100311719 | Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication - O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug. | 12-09-2010 |
20140170233 | Natural feed mixture for breeding domesticated water birds - The invention relates to a natural feed mixture for breeding domesticated water birds, comprising a high carbohydrate containing basic component poor in methyl-donors, a component rich in carbohydrates, having hepatic insulin-sensitizing properties, hypothalamic appetite-stimulating plant parts, natural substances blocking cholesterol synthesis in the liver, and an additive for protecting the formation of non-cholesterol- mevalonate products. | 06-19-2014 |
Zoltán Szilvássy, Debrecen HU
Patent application number | Description | Published |
---|---|---|
20120129769 | ORALLY ADMINISTERABLE PHARMACEUTICAL PREPARATION CONTAINING INSULIN - The subject of the invention is an orally administerable pharmaceutical preparation containing a combination of biotechnologically produced human recombinant insulin and/or modified insulin or an analogue and/or derivative thereof, a protease inhibitor and a high molecular weight (natural) protein. The invention relates to a method for the production of the pharmaceutical preparation as well. The subject of the invention also covers the use of the pharmaceutical preparation and a method for the treatment of diabetes in mammals. | 05-24-2012 |
Zoltán Szilvássy, Debrecen-Jozsa HU
Patent application number | Description | Published |
---|---|---|
20100311719 | Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication - O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug. | 12-09-2010 |
Zoltán Szinay, Dunaharaszti HU
Patent application number | Description | Published |
---|---|---|
20130274535 | PROCESS FOR TERMICAL DEGRADATION OF PVC AND OTHER WASTES CONTAINING HALOGEN-CONTAINING POLYMER WASTE - The subject matter of the patent is a process technology concerning thermal degradation of plastic wastes containing PVC and other plastic waste with halogen content. The patent is characterised by grinding of the plastic waste to be treated, leading it into a dehalogenisation reactor with heavy oil fraction added forming a 1:0.3-0.8 mass ratio plastic grinding: heavy oil mixture, warming the reaction compound up to a temperature of 210-2500 C, an acidic solution is formed from the hydrogen halogen gas liberated from the substance with the known method, it is removed, while the mixture retained in the reactor chamber is forwarded to the de-polymerisation reactor, where temperature is raised to at least 4800 C, but kept below 6000 C, the hydrocarbon gas mixture generated is extracted, separated into fractions, condensed, and the ratio of the heavy oil fraction referred to above as necessary for the processing of the waste is returned to the dehalogenisation reactor to form a mixture of plastic chippings and heavy oil. | 10-17-2013 |
Zoltán Takáts, Budapest HU
Patent application number | Description | Published |
---|---|---|
20090302211 | METHOD AND DEVICE FOR DESORPTION IONIZATION BY LIQUID JET - The invention relates to method and apparatus for production of gaseous ions from components of a condensed phase sample and analysis thereof, wherein one or more liquid jet(s) is/are directed to the surface of the sample to be investigated, where the impact of the liquid jet on the sample surface produces droplets carrying sample particles which are turned into gaseous ions via the evaporation of liquid or, if desired, by a subsequent ionization after the evaporation and the obtained sample particles are analyzed by a known method. | 12-10-2009 |
Zoltán Takáts, London GB
Patent application number | Description | Published |
---|---|---|
20130224785 | METHOD AND DEVICE FOR DESORPTION IONIZATION - The invention relates to method and apparatus for production of gaseous ions from components of a condensed phase sample and analysis thereof, wherein one or more liquid jet(s) is/are directed to the surface of the sample to be investigated, where the impact of the liquid jet on the sample surface produces droplets carrying sample particles which are turned into gaseous ions via the evaporation of liquid or, if desired, by a subsequent ionization after the evaporation and the obtained sample particles are analyzed by a known method. | 08-29-2013 |
Zoltán Tomori, Kosice Iv SK
Patent application number | Description | Published |
---|---|---|
20100042179 | Resuscitation device and method for resuscitation - The invention relates to a resuscitation device for humans. The resuscitation device is designed to provide resuscitating stimulation of the respiratory area of the human brain stem, preferably from a location distant from said respiratory area. The invention further relates to a method for providing a rescuscitating treatment to a human. Parameters are measured by a number of sensor means and processed by a processing means for providing a response by a number of stimulation means. The stimulation means are electrical, mechanical or chemical stimulation means. | 02-18-2010 |
Zoltán Tomori, Kosice Iv SK
Patent application number | Description | Published |
---|---|---|
20100042179 | Resuscitation device and method for resuscitation - The invention relates to a resuscitation device for humans. The resuscitation device is designed to provide resuscitating stimulation of the respiratory area of the human brain stem, preferably from a location distant from said respiratory area. The invention further relates to a method for providing a rescuscitating treatment to a human. Parameters are measured by a number of sensor means and processed by a processing means for providing a response by a number of stimulation means. The stimulation means are electrical, mechanical or chemical stimulation means. | 02-18-2010 |
20140025034 | RESUSCITATION DEVICE AND METHOD FOR RESUSCITATION - A method for providing a resuscitating treatment of a human being, which has the following actions sensing human muscle activity, human breathing activity, human neural activity or human cerebral activity, determining whether the human being is in a state of developing apnoea by a processing unit based on the sensing, provoking an induced aspiration reflex by a resuscitating stimulation of a respiratory area of a human brain stem by providing a stimulus with a stimulation device to a location distant from the respiratory area of the human brain stem upon the processing unit determining the state of developing apnoea, the location being a nasal filter of the human being or a nasopharyngeal area of the human being. | 01-23-2014 |
Zoltán Tóth, Budapest HU
Patent application number | Description | Published |
---|---|---|
20120224477 | PRUNED FORWARDING SET FOR SCALABLE TUNNELING APPLICATIONS IN DISTRIBUTED USER PLANE - A method and system for reducing congestion and latency in a communication system by creating a pruned forwarding set for scalable tunneling applications. The communication system provides a communication link between a mobile communication device and a network, such as the Internet. The method entails using information included within a data packet to determine a corresponding tunnel peer address, which is then resolved onto a set of paths. Each path includes respective adjacency information. A determination of whether to prune each respective path is made by using the respective adjacency information. The pruned set of paths is used to identify available paths for the communication link. By pruning in this manner, the line card being used as the home slot for a given session may also be used as the egress slot, thereby reducing congestion and latency in the communication system. | 09-06-2012 |
Zoltán Tóth, Sarbogard HU
Patent application number | Description | Published |
---|---|---|
20110173344 | SYSTEM AND METHOD OF REDUCING INTRANET TRAFFIC ON BOTTLENECK LINKS IN A TELECOMMUNICATIONS NETWORK - A system, method and node of masquerading remote hosts at the remote end of the bottleneck link without breaking layer 2 transparency using a cache mechanism. A local edge node stores specified objects of the remote host. Upon request of an initiator host, the edge node sends the stored object to the initiator host without requiring the transfer of the object from the remote host. The present invention also provides for the election of a Local Master Browser (LMB). The method consists of electing one LMB for spreading information for each LAN segment, instead of having one such global node for the entire LAN. The present invention elects one local LMB for each LAN segment, rather than using one global LMB node. | 07-14-2011 |
Zoltán Tuba, Budapest HU
Patent application number | Description | Published |
---|---|---|
20090312299 | Isolated Isomers of Norelgestromin and Methods of Making and Using the Same - The invention is directed to a process of preparing substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-3E- and -3Z-oxime isomers, as well as a process for the synthesis of the mixture of isomers and the pure isomers. The invention also relates to substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene20-yn-3-one-3E-oxime and substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-3Z-oxime isomer. Further aspects of the invention include a composition comprising substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene20-yn-3-one-3E-oxime or substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-3Z-oxime isomer, and methods of treatment using said compositions. | 12-17-2009 |
20100137622 | INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11beta-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-- DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS - The present invention relates to a process for the synthesis of the known 17-acetoxy-11-β-[4-(dimethyl amino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione (further on CDB-4124) of formula (I) from 3,3-[1,2-ethandiyl-bis(oxy)]-oestr-5(10),9(11)-dien-17-one of formula (II). Compound CDB-4124 belongs to the group of anti-hormones. The process has the following steps: i) formation of an epoxide; ii) addition of hydrogen cyanide; iii) silylation of a hydroxyl group; iv) reaction with 4-(dimethylamino)-phenyl magnesium bromide Grignard reagent in the presence of CuCl (Teutsch reaction); v) silylation of a hydroxyl group with trimethyl chlorosilane; vi) reaction with diisobutyl aluminum hydride and after addition of acid to the reaction mixture; vii) methoxy-methylation with methoxy-methyl Grignard reagent formed in situ, while hydrolyzing the trimethylsilyl protective groups; viii) oxidation of a hydroxyl group with dicyclohexyl carbodiimide in the presence of dimethyl sulfoxide and a strong organic acid (Swern oxidation), and in given case after purification by chromatography; ix) acetylation of a hydroxyl group with acetic anhydride in the presence of perchloric acid, and in given case, purification by chromatography. The invention also relates to new intermediates of the process. | 06-03-2010 |
Zoltán Tuba, Budapest HU
Patent application number | Description | Published |
---|---|---|
20080200668 | Industrial Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene-3-Oxo-17Alpha-Pregn-4-Ene-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process - The invention relates to an industrial process for the preparation of 17-hydroxy-6β,7β;15β,16β-bismethylene-3-oxo-17α-pregn-4-ene-21-carboxylic acid γ-lactone of formula (I), and to the key-intermediates for this process. | 08-21-2008 |
20090187032 | INDUSTRIAL PROCESS FOR THE SYNTHESIS OF 17alpha-ACETOXY-11beta-[4-(N,N-DIMETHYL-AMINO)-PHENYL]-19-NORPREGNA-4,9-D- IENE-3,20-DIONE AND NEW INTERMEDIATES OF THE PROCESS - The present invention relates to a new industrial process for the synthesis of solvate-free 17α-acetoxy-11β-[4-(N,N-dimethyl-amino)-phenyl]-19-norpregna-4,9-diene-3,20-dione [CDB-2914] of formula (I) which is a strong antiprogestogene and antiglucocorticoid agent. The invention also relates to compounds of formula (VII) and (VIII) used as intermediates in the process. | 07-23-2009 |
20090312299 | Isolated Isomers of Norelgestromin and Methods of Making and Using the Same - The invention is directed to a process of preparing substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-3E- and -3Z-oxime isomers, as well as a process for the synthesis of the mixture of isomers and the pure isomers. The invention also relates to substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene20-yn-3-one-3E-oxime and substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-3Z-oxime isomer. Further aspects of the invention include a composition comprising substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene20-yn-3-one-3E-oxime or substantially pure d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-3Z-oxime isomer, and methods of treatment using said compositions. | 12-17-2009 |
20100137622 | INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11beta-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-- DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS - The present invention relates to a process for the synthesis of the known 17-acetoxy-11-β-[4-(dimethyl amino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione (further on CDB-4124) of formula (I) from 3,3-[1,2-ethandiyl-bis(oxy)]-oestr-5(10),9(11)-dien-17-one of formula (II). Compound CDB-4124 belongs to the group of anti-hormones. The process has the following steps: i) formation of an epoxide; ii) addition of hydrogen cyanide; iii) silylation of a hydroxyl group; iv) reaction with 4-(dimethylamino)-phenyl magnesium bromide Grignard reagent in the presence of CuCl (Teutsch reaction); v) silylation of a hydroxyl group with trimethyl chlorosilane; vi) reaction with diisobutyl aluminum hydride and after addition of acid to the reaction mixture; vii) methoxy-methylation with methoxy-methyl Grignard reagent formed in situ, while hydrolyzing the trimethylsilyl protective groups; viii) oxidation of a hydroxyl group with dicyclohexyl carbodiimide in the presence of dimethyl sulfoxide and a strong organic acid (Swern oxidation), and in given case after purification by chromatography; ix) acetylation of a hydroxyl group with acetic anhydride in the presence of perchloric acid, and in given case, purification by chromatography. The invention also relates to new intermediates of the process. | 06-03-2010 |
Zoltán Turányi, Szentendre HU
Patent application number | Description | Published |
---|---|---|
20110216680 | Method And Apparatus For Use In A Communications Network - According to a first aspect of the present invention there is provided a method of routing traffic in a communications network employing Proxy Mobile IP, in which a traffic flow has been transferred from a first interface of a multi-homed mobile node, having a first IP address, to a second interface of the multi-homed mobile node, having a second IP address. The method comprises, at the mobile node and at a mobility anchor function, performing forward and reverse address translation between the first IP address and the second IP address. | 09-08-2011 |
20120265888 | METHOD AND APPARATUS FOR GATEWAY SESSION ESTABLISHMENT - A method for deploying a policy from a 3GPP core network to a non-3GPP access network. The policy relates to a connection established from a mobile terminal to the 3GPP core network via the non-3GPP access network. A local IP address acquired by the mobile terminal during establishment of the connection is received at the 3GPP core network. At the 3GPP core network, establishment of a policy control session is initiated from the 3GPP core network to the non-3GPP access network. The received local IP address is used to determine the non-3GPP access network used for the connection with reference to shared IP addressing information. At the 3GPP core network, the policy is provided to the non-3GPP access network using the policy control session established as a result of the policy control session initiation step. The policy is for deployment in the non-3GPP access network in relation to the established connection. | 10-18-2012 |
20130148513 | CREATING PACKET TRAFFIC CLUSTERING MODELS FOR PROFILING PACKET FLOWS - Packet traffic profiling models are created based on packet headers of a packet flow at a first model aggregation level to obtain first flow information describing packet-oriented parameters of the flow. A machine learning algorithm (MLA) creates a first model based on the first information, determines if the first model achieves a first confidence level, and if not, defines multiple flow slices in the packet flow. Flow slices at a second higher model aggregation level are processed to obtain second flow information describing flow slice-oriented parameters of the packet flow, and an MLA creates a second model based on the second information to determine if the second model achieves a second confidence level. If so, the process completes; if not, further processing continues at a next level. One of the models is selected for profiling packet traffic flows. | 06-13-2013 |
Zoltán Varga, Budapest HU
Patent application number | Description | Published |
---|---|---|
20100081668 | POLYMORPHS OF 5--6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE HYDROBROMIDE AND PROCESSES FOR PREPARATION THEREOF - The present invention provides pharmaceutically applicable compounds and polymorphs belonging to the ziprasidone hydrobromide compound group with antipsychotic effect. The present invention provides hydrobromide polymorphs of 5-{-2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one, ziprasidone of Formula (I) having neuroleptic activity. | 04-01-2010 |
20120258968 | 4-PHENYLAMINO-PYRIMIDINE DERIVATIVES HAVING PROTEIN KINASE INHIBITOR ACTIVITY - The invention relates compounds of general formula (I) and pharmaceutically acceptable salts and solvates thereof wherein | 10-11-2012 |
20130225695 | METHOD FOR PREPARATION OF AN EXCIPIENT SUITABLE FOR PHARMACEUTICAL USE - The present invention is related to a method for purifying diatomaceous earth wherein the natural colloidal structure of the material is retained, which comprises preparing a suspension of diatomaceous earth in a liquid wherein diatomaceous earth is insoluble, separating diatomaceous earth from the suspension, treating diatomaceous earth with an inorganic or organic acid, heat-treating the thus obtained product at a temperature not higher than 300° C., subjecting the product obtained to oxidative treatment and drying the purified product. | 08-29-2013 |
Zoltán Váthy, Zalaszentgrot HU
Patent application number | Description | Published |
---|---|---|
20120217314 | EAS PIN COMBINED WITH A PLASTIC ENCAPSULATED RFID TAG TO BE CONNECTED TO AN EAS LABEL, PARTICULARLY FOR TRACKING ARTICLES OF CLOTHING - An anti theft tag with separated encapsulated RFID tag and an EAS label, wherein the tag comprises a first plastic body equipped with an EAS label, a second plastic body in which a pin engagable to an EAS label is accommodated, said pin is releasably lockable to a locking mechanism of the EAS label, the pin has a head and a stem formed so that it may be engaged with the locking mechanism of the EAS label, and further, the second plastic body contains an RFID inlay. Said plastic body can be injection moulded onto said RFID tag. The operating frequency band of the RFID tag is adjusted by the material of the plastic body and the thickness of the material encapsulating said RFID tag. The material of the plastic body preferably comprises a filling material having a relative dielectric constant exceeding that of the base material. The RFID tag can be inserted into a cavity of said plastic body composed of two parts defining said cavity. | 08-30-2012 |
Zoltán Von Mohos, Pulheim DE
Patent application number | Description | Published |
---|---|---|
20120132308 | DEVICE FOR RECEIVING LIQUIDS IN AIRCRAFT AND/OR RELEASING LIQUIDS THEREFROM - The invention relates to a device for receiving liquids in an aircraft and/or releasing liquids therefrom, especially during the flight, said device being arranged especially in an airplane. The aim of the invention is to provide a device which can receive large quantities of liquids in a rapid, reliable and flexible manner. To this end, the device can include a tank module with at least one tank container that is connected to a collector using a connecting shaft and a bulkhead module that can be connected to the tank module by the collecting tank. A closing element in the open position releases liquid from the tank module. In addition, a refueling module which is connected to the tank module by a supply line and a tube arranged on a winding device, and a receiving element attached to the tube, can provide refueling of the device. | 05-31-2012 |